< Back

STRATEGIC EXPANSION OF OTC PORTFOLIO CONTINUES – STADA ACQUIRES EMEA RIGHTS TO GLOBAL ANTI-DANDRUFF BRAND NIZORAL FROM JANSSEN PHARMACEUTICA

  • 28/06/2018
  • Press Release

Bad Vilbel, June 28, 2018 – STADA Arzneimittel AG is further strengthening its position in branded over-the-counter healthcare products. The company has acquired the rights to the medicated anti-dandruff shampoo Nizoral from Janssen Pharmaceutica NV (a member of the Johnson & Johnson family of companies). The shampoo generated sales of approximately EUR 33 million in EMEA (Europe, Middle East, and Africa) in 2017.